Cargando…
Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs
Marine drugs have long been used and exhibit unique advantages in clinical practices. Among the marine drugs that have been approved by the Food and Drug Administration (FDA), the protein–ligand interactions, such as cytarabine–DNA polymerase, vidarabine–adenylyl cyclase, and eribulin–tubulin comple...
Autores principales: | Chen, Guilin, Seukep, Armel Jackson, Guo, Mingquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692358/ https://www.ncbi.nlm.nih.gov/pubmed/33143025 http://dx.doi.org/10.3390/md18110545 |
Ejemplares similares
-
Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification
por: Seukep, Armel Jackson, et al.
Publicado: (2020) -
In Vitro Antibacterial and Antiproliferative Potential of Echinops lanceolatus Mattf. (Asteraceae) and Identification of Potential Bioactive Compounds
por: Jackson Seukep, Armel, et al.
Publicado: (2020) -
Recent Advances in Drug Discovery from South African Marine Invertebrates
por: Davies-Coleman, Michael T., et al.
Publicado: (2015) -
Antiproliferative and Enzyme Docking Analysis of Engleromycin from Engleromyces goetzei
por: Zhang, Yongli, et al.
Publicado: (2019) -
Molecular Docking: Shifting Paradigms in Drug Discovery
por: Pinzi, Luca, et al.
Publicado: (2019)